Dermavant Sciences GmbH clinical trials
Acquired by Organon & Co., Oct 28, 2024 · source ↗
The registry lists 4 studies whose lead sponsor is Dermavant Sciences GmbH. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 24, 2020.
Before and after it joined Organon & Co.
- First submitted before Dermavant Sciences GmbH became part of Organon & Co.
- 4
- First submitted after Dermavant Sciences GmbH became part of Organon & Co.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Dermavant Sciences GmbH4 studies
Something wrong with this grouping? Tell us on the Organon & Co. page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Organon & Co. studies →
- Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With VitiligoCompletedNCT04103060Phase 2
Sponsor listed in the registry: Dermavant Sciences GmbH · First submitted before Dermavant Sciences GmbH became part of Organon & Co.
- Study of RVT-501 in Adult and Adolescent Subjects With Atopic DermatitisCompletedNCT02950922Phase 2
Sponsor listed in the registry: Dermavant Sciences GmbH · First submitted before Dermavant Sciences GmbH became part of Organon & Co.
- Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03394677Phase 2
Sponsor listed in the registry: Dermavant Sciences GmbH · First submitted before Dermavant Sciences GmbH became part of Organon & Co.
- Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisStatus unknownNCT03415282Phase 1
Sponsor listed in the registry: Dermavant Sciences GmbH · First submitted before Dermavant Sciences GmbH became part of Organon & Co.